» Articles » PMID: 22555470

Mapping Analyses to Estimate EQ-5D Utilities and Responses Based on Oxford Knee Score

Overview
Journal Qual Life Res
Date 2012 May 5
PMID 22555470
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The Oxford Knee Score (OKS) is a validated 12-item measure of knee replacement outcomes. An algorithm to estimate EQ-5D utilities from OKS would facilitate cost-utility analysis on studies analyses using OKS but not generic health state preference measures. We estimate mapping (or cross-walking) models that predict EQ-5D utilities and/or responses based on OKS. We also compare different model specifications and assess whether different datasets yield different mapping algorithms.

Methods: Models were estimated using data from the Knee Arthroplasty Trial and the UK Patient Reported Outcome Measures dataset, giving a combined estimation dataset of 134,269 questionnaires from 81,213 knee replacement patients and an internal validation dataset of 45,213 questionnaires from 27,397 patients. The best model was externally validated on registry data (10,002 observations from 4,505 patients) from the South West London Elective Orthopaedic Centre. Eight models of the relationship between OKS and EQ-5D were evaluated, including ordinary least squares, generalized linear models, two-part models, three-part models and response mapping.

Results: A multinomial response mapping model using OKS responses to predict EQ-5D response levels had best prediction accuracy, with two-part and three-part models also performing well. In the external validation sample, this model had a mean squared error of 0.033 and a mean absolute error of 0.129. Relative model performance, coefficients and predictions differed slightly but significantly between the two estimation datasets.

Conclusions: The resulting response mapping algorithm can be used to predict EQ-5D utilities and responses from OKS responses. Response mapping appears to perform particularly well in large datasets.

Citing Articles

A systematic review of crosswalks for converting patient-reported outcome measure scores in hip, knee, and shoulder replacement surgery.

Ackerman I, Soh S, Hallstrom B, Fang Y, Franklin P, Lutzner J Acta Orthop. 2024; 95:512-523.

PMID: 39268815 PMC: 11494241. DOI: 10.2340/17453674.2024.41384.


Global mapping of institutional and hospital-based (Level II-IV) arthroplasty registries: a scoping review.

Zgouridou A, Kenanidis E, Potoupnis M, Tsiridis E Eur J Orthop Surg Traumatol. 2023; 34(2):1219-1251.

PMID: 37768398 PMC: 10858160. DOI: 10.1007/s00590-023-03691-y.


Mapping the EQ-5D-5L from the Spanish national health survey functional disability scale through Bayesian networks.

Ayala A, Ramallo-Farina Y, Bilbao-Gonzalez A, Forjaz M Qual Life Res. 2023; 32(6):1785-1794.

PMID: 36735174 DOI: 10.1007/s11136-023-03351-y.


Mapping of disease-specific Oxford Knee Score onto EQ-5D-5L utility index in knee osteoarthritis.

Fawaz H, Yassine O, Hammad A, Bedwani R, Abu-Sheasha G J Orthop Surg Res. 2023; 18(1):84.

PMID: 36732785 PMC: 9896832. DOI: 10.1186/s13018-023-03522-0.


Mapping analysis to predict the associated EuroQol five-dimension three-level utility values from the Oxford Knee Score : a prediction and validation study.

Clement N, Afzal I, Peacock C, MacDonald D, Macpherson G, Patton J Bone Jt Open. 2022; 3(7):573-581.

PMID: 35837809 PMC: 9350693. DOI: 10.1302/2633-1462.37.BJO-2022-0054.R1.


References
1.
Reddy K, Johnston L, Wang W, Abboud R . Does the Oxford Knee Score complement, concur, or contradict the American Knee Society Score?. J Arthroplasty. 2010; 26(5):714-20. DOI: 10.1016/j.arth.2010.05.032. View

2.
Rothwell A, Hooper G, Hobbs A, Frampton C . An analysis of the Oxford hip and knee scores and their relationship to early joint revision in the New Zealand Joint Registry. J Bone Joint Surg Br. 2010; 92(3):413-8. DOI: 10.1302/0301-620X.92B3.22913. View

3.
Murray D, Fitzpatrick R, Rogers K, Pandit H, Beard D, Carr A . The use of the Oxford hip and knee scores. J Bone Joint Surg Br. 2007; 89(8):1010-4. DOI: 10.1302/0301-620X.89B8.19424. View

4.
Kind P . Measuring quality of life in evaluating clinical interventions: an overview. Ann Med. 2001; 33(5):323-7. DOI: 10.3109/07853890109002085. View

5.
Rivero-Arias O, Ouellet M, Gray A, Wolstenholme J, Rothwell P, Luengo-Fernandez R . Mapping the modified Rankin scale (mRS) measurement into the generic EuroQol (EQ-5D) health outcome. Med Decis Making. 2009; 30(3):341-54. DOI: 10.1177/0272989X09349961. View